Sunshine Biopharma Inc. Annual Return On Assets in % from 2011 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sunshine Biopharma Inc. quarterly/annual Return On Assets history and growth rate from 2011 to 2024.
  • Sunshine Biopharma Inc. Return On Assets for the quarter ending December 31, 2024 was -16.9 %, a 3.25% decline year-over-year.
  • Sunshine Biopharma Inc. annual Return On Assets for 2024 was -16.9 %, a 3.25% decline from 2023.
  • Sunshine Biopharma Inc. annual Return On Assets for 2023 was -16.3 %, a 80.8% increase from 2022.
  • Sunshine Biopharma Inc. annual Return On Assets for 2022 was -85.2 %, a 85.6% increase from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -16.9 -0.53 -3.25% Jan 1, 2024 Dec 31, 2024
2023 -16.3 +68.9 +80.8% Jan 1, 2023 Dec 31, 2023
2022 -85.2 +508 +85.6% Jan 1, 2022 Dec 31, 2022
2021 -594 +25.7 +4.15% Jan 1, 2021 Dec 31, 2021
2020 -619 -204 -49.3% Jan 1, 2020 Dec 31, 2020
2019 -415 -220 -113% Jan 1, 2019 Dec 31, 2019
2018 -195 +398 +67.1% Jan 1, 2018 Dec 31, 2018
2017 -593 +31.9 +5.11% Jan 1, 2017 Dec 31, 2017
2016 -625 -39.9 -6.81% Jan 1, 2016 Dec 31, 2016
2015 -585 +1.17K +66.7% Jan 1, 2015 Dec 31, 2015
2014 -1.76K +147 +7.7% Jan 1, 2014 Dec 31, 2014
2013 -1.91K -1.43K -301% Jan 1, 2013 Dec 31, 2013
2012 -475 -123 -35.1% Jan 1, 2012 Dec 31, 2012
2011 -352 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.